High-resolution anoscopy market seen reaching $22.43B by 2030

The Business Research Company says the global high-resolution anoscopy market will grow from $16 billion in 2025 to $17 billion in 2026, then reach $22.43 billion by 2030. The report points to rising cancer prevalence, more STIs, and wider use of advanced diagnostic tools as the main demand drivers.

Why it matters: - The high-resolution anoscopy market is expanding as health systems look for earlier, more precise ways to detect anal cancer and anal intraepithelial neoplasia. - The category sits at the intersection of cancer screening, STI management and minimally invasive diagnostics. - The report frames the market as part of a broader shift toward more portable, digital and AI-assisted medical imaging tools.

What happened: - The Business Research Company published its High-Resolution Anoscopy Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report says the market will grow from $16 billion in 2025 to $17 billion in 2026, a 6.2% CAGR. - The market is forecast to reach $22.43 billion by 2030, growing at a 7.2% CAGR. - North America held the largest market share in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - Download a free sample of the report. - View the full market report.

The details: - High-resolution anoscopy is a specialized technique used to examine the anal canal and lower rectum with detailed magnification. - The procedure is used to detect and assess abnormalities including anal intraepithelial neoplasia, anal cancer and other conditions in the anal area. - The report links recent market growth to heightened awareness of anal cancer and AIN. - Other drivers include the expansion of specialized diagnostic centers, colposcopy-based diagnostic techniques, better visualization during anoscopy and preventive screening programs. - Future growth is tied to funding for early cancer detection, stronger demand for portable diagnostic devices and broader use of telemedicine-supported diagnostics. - The report also points to advances in AI-driven image analysis and greater use of minimally invasive diagnostic procedures. - Anticipated trends include wider adoption of digital and portable anoscopy tools, enhanced high-resolution imaging for early diagnosis, expanded anal cancer screening programs, more outpatient diagnostic services and better image documentation systems.

Between the lines: - Rising cancer prevalence is a major demand signal for the market. - The American Cancer Society reported in January 2024 that U.S. cancer cases rose to 2,001,140 from 1,958,310 in 2023. - Rising sexually transmitted infections are another growth driver because HPV can lead to anal dysplasia. - UNAIDS said in July 2025 that about 40.8 million people worldwide were living with HIV in 2024, along with 1.3 million new infections. - The report suggests clinical need, not just technology adoption, is pushing demand for high-resolution anoscopy systems.

What's next: - The market is expected to keep growing as screening expands and diagnostic tools become more portable and digitally connected. - Adoption should rise as providers lean more on AI-assisted analysis and outpatient workflows. - Regional competition will likely remain strongest in North America while other geographies build out screening and diagnostic capacity.

The bottom line: - High-resolution anoscopy is moving from a niche diagnostic tool toward a broader cancer-screening market, with growth supported by rising disease burden and faster-evolving imaging technology.